Tute Genomics Acquired By PierianDX
Provo, Utah-based Tute Genomics, which was developing personalized medicine and genomics software, has been acquired by PierianDX, a provider of clinical genomic analysis, interpretation, and reporting software. Financial details of the acquisition were not announced. As part of the funding, PierianDX said that Tute's CEO, Reid Robison, will join its board, and that Tute COO Andy Olson and VP of Product Development Bryce Daines with both relocate to St. Louis, where the company is headquartered. PierianDx said it will continue to maintain a development team in Provo. PierianDX was backed by Eurovesttech, Peak Ventures and angels.
posted on Wednesday, October 12, 2016
Related companies:
Tute Genomics, Inc.
Related stories:
> Tute Genomics Gets $2.3M For Personalized Medicine
> Peak Ventures Invests $500K In Tute Genomics
> Zayo Wins Genomics Customer
> Peak Ventures Aims To Raise Second Venture Capital Fund
> Healthbox Selects Ten Startups For Accelerator
Techrockies.com Home